Advertisement
News
Advertisement

With cancer drug in trials, Mersana gets $6M

Fri, 04/22/2011 - 5:37am
Mass High Tech: The Journal of New England Technology

Mersana Therapeutics Inc has raised $6 million of a planned $10 million debt round with private investors, the company reported in a regulatory filing on Thursday. 

The Cambridge company develops medicines using a proprietary, biodegradable polymer it calls Fleximer.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading